Physician profile
Sarav Shah
NPI 1114284288
$90,244.29
in general payments reported to CMS, 2019-2025
32 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,057 · 2020: $2,848 · 2021: $13K · 2022: $27K · 2023: $7,209 · 2024: $15K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $7,675 · Food and Beverage: $7,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,949.32 |
| Travel and Lodging | $7,675.22 |
| Food and Beverage | $7,127.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $48,802.58 | 2019-2025 | |
| Arthrex, INC. | $7,491.80 | 2019-2025 | Arthrex |
| Kairos Surgical INC | $7,150.83 | 2019-2024 | |
| Vericel Corporation | $5,850.19 | 2021-2024 | Maci |
| Medical Device Business Services, INC. | $5,678.02 | 2022-2023 | |
| Osteoremedies, LLC | $4,113.60 | 2025 | Remedy Spacer, Osteoboost Select 5cc, Biobrush |
| Depuy Synthes Products, INC. | $2,340.00 | 2022 | |
| Stryker Corporation | $2,328.79 | 2019-2025 | Air, Crossfire, Iconix |
| Encore Medical, LP | $1,508.38 | 2019 | |
| Banner Surgical Solutions, INC | $1,154.80 | 2025 | |
| Anika Therapeutics, INC. | $511.04 | 2020-2025 | Tactoset, Integrity |
| Smith+Nephew, INC. | $408.57 | 2019-2024 | N/A |
| Bone Support INC. | $345.73 | 2020-2024 | Cerament G, Ceramentbone Void Filler |
| Zimmer Biomet Holdings, INC. | $305.88 | 2021-2025 | Comprehensive Shoulder System |
| Orthofix Medical, INC. | $261.13 | 2019-2023 | Physio-Stim |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $248.98 | 2022-2025 | Exparel, Iovera, Zilretta |
| Catalyst Orthoscience | $203.55 | 2022-2025 | |
| Linvatec Corporation | $185.11 | 2023 | Biobrace 23mm |
| Miach Orthopaedics, INC. | $170.50 | 2022 | |
| Acumed LLC | $159.53 | 2021-2023 | Acumed |
| Depuy Synthes Sales INC. | $140.97 | 2023 | |
| Heron Therapeutics, INC. | $132.77 | 2023-2024 | Zynrelef |
| Innovation Technologies INC | $119.29 | 2021 | |
| Avanos Medical | $116.79 | 2021 | |
| Baxter Healthcare | $115.37 | 2025 | Floseal |
| Vertex Pharmaceuticals Incorporated | $114.30 | 2025 | |
| Bioventus LLC | $111.70 | 2021-2025 | Durolane, Durolane |
| Elite Orthopedics, LLC | $73.35 | 2024 | |
| Djo, LLC | $34.99 | 2019 | |
| Pacira Therapeutics, INC. | $32.61 | 2019 | |
| Endo Pharmaceuticals INC. | $19.33 | 2021 | |
| Ferring Pharmaceuticals INC. | $13.81 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarav Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.